C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV....
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trim...
Top Cities for Hepatitis C Clinical Trials
Hepatitis C clinical trials are recruiting across 16 cities. Here are the cities with the most active studies:
About Hepatitis C
Hepatitis C is a viral infection that causes liver inflammation and can lead to serious liver damage. Direct-acting antiviral medications can now cure over 95% of chronic hepatitis C cases. Ongoing research focuses on increasing access to treatment and preventing reinfection.
Clinical trials are advancing new treatments for hepatitis c. Currently, 2 studies are recruiting a combined 980 participants across the United States. Research is being conducted by 2 organizations including Atea Pharmaceuticals, Inc., Catherine Anne Chappell.
2026 Hepatitis C Research Landscape
As of March 2026, the hepatitis c clinical trial landscape includes 2 actively recruiting studies across 16 cities in the United States. These studies are collectively seeking 980 participants, with an average enrollment target of 490 per study.
Research is being led by 2 different organizations, including Atea Pharmaceuticals, Inc., Catherine Anne Chappell.
Geographically, hepatitis c trials are most concentrated in Phoenix, Arizona (2 trials); Toronto, Ontario (2 trials); Birmingham, Alabama (1 trial); Dothan, Alabama (1 trial); Chandler, Arizona (1 trial) and 7 other cities.
Featured Hepatitis C Studies
Highlighted recruiting studies for hepatitis c, selected by enrollment size and research scope.
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trimester in approximately 100 pregnant people. Maternal participants will take one SOF/VEL tablet once daily for 12 weeks (84 days) and followed until 12 weeks after treatment completion (postpartum). In...
Frequently Asked Questions About Hepatitis C Clinical Trials
Are there hepatitis c clinical trials near me?
Yes, there are 2 hepatitis c clinical trials currently recruiting across 16+ cities in the United States, including Phoenix, Arizona; Toronto, Ontario; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a hepatitis c clinical trial?
To join a hepatitis c clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are hepatitis c clinical trials free?
Yes, participation in hepatitis c clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of hepatitis c treatments are being studied?
Current hepatitis c clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in hepatitis c clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 2, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov